@article{a794b05f186d456cbcef8a2936c0c5f2,
title = "Optimizing the Patient Experience and Satisfaction: The Role of Topical NSAIDs with Intravitreal Injections",
author = "Kaplan, {Richard I.} and Rosen, {Richard B.} and Gentile, {Ronald C.}",
note = "Funding Information: Financial Disclosure(s): The author(s) have made the following disclosure(s): R.B.R.: Consultant – Optovue, Boehringer-Ingelheim, Astellas, Bayer, Nano Retina, Guardion Health, Regeneron, Genentech-Roche, OD-OS, Diopsys, CellView; Patents – Optovue, Opticology. R.C.G.: Consultant – Alcon Laboratories, Inc; Financial support – Acucela, Genentech, GlaxoSmithKline, Notal Vision, Inc, Quark Pharmaceuticals, Regeneron Pharmaceuticals, Inc. Juvenile Diabetes Research Foundation, New York, NY, the National Eye Institute, National Institutes of Health, Bethesda, Maryland, New York Eye & Ear Infirmary, Mount Sinai Health System, New York, New York, University of Wisconsin, Madison, Wisconsin, Diabetic Retinopathy Clinical Research Network, Tampa, Florida.",
year = "2020",
month = may,
doi = "10.1016/j.oret.2020.03.004",
language = "English",
volume = "4",
pages = "459--460",
journal = "Ophthalmology Retina",
issn = "2468-6530",
publisher = "Elsevier Inc.",
number = "5",
}